Print pageEmail pageRSS Feeds

News releases

<< Back
ARIAD to Present at the Cowen and Company 32nd Annual Health Care Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 27, 2012-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will webcast its presentation at the Cowen and Company 32nd Annual Health Care Conference in Boston. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company’s business on Tuesday, March 6, 2012 at 9:20 a.m. (ET).

The ARIAD presentation at the Cowen and Company 32nd Annual Health Care Conference will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor. A replay of the webcast presentation will also be available and archived on the site for three weeks.

About ARIAD

ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. ARIAD’s approach to structure-based drug design has led to three internally discovered, molecularly targeted product candidates for drug-resistant and difficult-to-treat cancers, including certain forms of chronic myeloid leukemia, soft tissue and bone sarcomas and non-small cell lung cancer. For additional information, visit http://www.ariad.com.

Source: ARIAD Pharmaceuticals, Inc.

ARIAD Pharmaceuticals, Inc.
For Investors
Maria E. Cantor, 617-621-2208
Maria.cantor@ariad.com
or
For Media
Liza Heapes, 617-621-2315
Liza.heapes@ariad.com

You are now leaving this website. If you would like to continue, click Continue.
CancelContinue